I Had a Dream ... about Uncitedness

My first paper proposing the creation of the Science Citation Index® (Science, 122(3159): 108-111, 1955) began with a quotation from P. Thomasson and J.C. Stanley: "The uncritical citation of disputed data by a writer, whether it be deliberate or not, is a serious matter. Of course, knowingly propagandizing unsubstantiated claims is particularly abhorrent, but just as many naïve students may be swayed by unfounded assertions presented by a writer who is unaware of the criticisms. Burie

Written byEugene Garfield
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

My first paper proposing the creation of the Science Citation Index® (Science, 122(3159): 108-111, 1955) began with a quotation from P. Thomasson and J.C. Stanley: "The uncritical citation of disputed data by a writer, whether it be deliberate or not, is a serious matter. Of course, knowingly propagandizing unsubstantiated claims is particularly abhorrent, but just as many naïve students may be swayed by unfounded assertions presented by a writer who is unaware of the criticisms. Buried in scholarly journals, critical notes are increasingly likely to be overlooked with the passage of time, while the studies to which they pertain, having been reported more widely, are apt to be rediscovered."

When the Science Citation Index (SCI®) was finally launched in the sixties, I dreamt that, one day, scholars would use it to routinely avoid the unwitting perpetuation of errors. Today I can still only hope that the World Wide Web and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies